Form D · Biotechnology

Tectonic Therapeutic, Inc.

Watertown, MA · CIK 0001681087

Offering snapshot reported Feb 14, 2025 · SEC filing

Reported sold
$185M
Offering amount: $185M
Investors reported
29
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Feb 5, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Feb 14, 2025Initial$185,027,642No comparison29SEC filing
Feb 2, 2018Initial$60,499,978No comparison15SEC filing
Aug 3, 2016Initial$7,500,000No comparison3SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$11.1M
Finders' fees
$0
Form D file number
021-538387

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
TD Securities (USA) LLC18476
Leerink Partners LLC39011
Piper Sandler & Co.665
Wells Fargo Securities, LLC126292

Source: Form D, filed Feb 14, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Bruce Booth Director
Ian Clark Director
Phillip B. Donenberg Director
Katina Dorton Executive
Daniel Lochner Executive
Geoffrey Mac Kay Director, Executive
Christopher Mason Executive
Terrance Mc Guire Director
Peter Mc Namara Executive
Christopher Paige Director
Deanna Petersen Executive
Alise Reicin Director, Executive
Scott Requadt Director
Joshua Resnick Director
Marcella K. Ruddy Executive
Marc Schwabish Executive
Timothy Springer Director
Praveen P. Tipirneni Director
Stefan Vitorovic Director
Kim Warren Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
490 Arsenal Way Suite 210
Watertown, MA, 02472